50-155-9490

USP20/VDU2 Polyclonal Antibody, Bethyl Laboratories

Manufacturer: Bethyl Laboratories, Inc

Select a Size

Pack Size SKU Availability Price
Each of 1 50-155-9490-Each-of-1 In Stock ₹ 12,384.35

50-155-9490 - Each of 1

₹ 12,384.35

In Stock

Quantity

1

Base Price: ₹ 12,384.35

GST (18%): ₹ 2,229.183

Total Price: ₹ 14,613.533

Antigen

USP20/VDU2

Classification

Polyclonal

Formulation

TBS with 0.1% BSA and 0.09% sodium azide

Gene Accession No.

Q8C6M1, Q9Y2K6

Gene Symbols

Usp20

Immunogen

Between 863 and 913

Quantity

20 μL

Primary or Secondary

Primary

Target Species

Human, Mouse

Product Type

Antibody

Isotype

IgG

Applications

Western Blot

Conjugate

Unconjugated

Gene

USP20

Gene Alias

USP20; VDU2; ubiquitin specific protease 20; KIAA1003; pVHL-interacting deubiquitinating enzyme 2; ubiquitin specific peptidase 20; LSFR3A

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

10868, 74270

Content And Storage

4° C

Form

Liquid

Related Products

Img

Bethyl Laboratories, Inc

50-156-8760

--

Img

Bethyl Laboratories, Inc

50-156-8231

--

Img

Bethyl Laboratories, Inc

50-156-8626

--

Img

Bethyl Laboratories, Inc

50-156-2226

--

Img

Bethyl Laboratories, Inc

50-156-3128

--

Img

Bethyl Laboratories, Inc

50-156-8758

--

Img

Bethyl Laboratories, Inc

50-156-0243

--

Img

Bethyl Laboratories, Inc

50-156-3125

--

Description

  • The recommended shelf life for this product is 1 year from date of receipt
  • Deubiquitinating enzyme involved in beta-2 adrenergic receptor (ADRB2) recycling
  • Acts as a regulator of G-protein coupled receptor (GPCR) signaling by mediating the deubiquitination beta-2 adrenergic receptor (ADRB2)
  • Plays a central role in ADRB2 recycling and resensitization after prolonged agonist stimulation by constitutively binding ADRB2, mediating deubiquitination of ADRB2 and inhibiting lysosomal trafficking of ADRB2
  • Upon dissociation, it is probably transferred to the translocated beta-arrestins, possibly leading to beta-arrestins deubiquitination and disengagement from ADRB2
  • This suggests the existence of a dynamic exchange between the ADRB2 and beta-arrestins
  • Deubiquitinates DIO2, thereby regulating thyroid hormone regulation
  • Deubiquitinates HIF1A, leading to stabilize HIF1A and enhance HIF1A-mediated activity
  • Mediates deubiquitination of both ′Lys-48′- and ′Lys-63′-linked polyubiquitin chains.